BioCentury
ARTICLE | Financial News

Aldexa Therapeutics proposes IPO

January 13, 2014 8:00 AM UTC

Aldexa Therapeutics Inc., Burlington, Mass. Business: Autoimmune, Ophthalmic Date announced: 1/6/14 Type: IPO To be raised: Up to $20.8 million Shares: TBD Price: TBD Underwriter: Aegis Capital Note: ...